Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Dopamine Receptor
    (12)
  • AChR
    (5)
  • 5-HT Receptor
    (4)
  • MAO
    (4)
  • Monoamine Oxidase
    (4)
  • Autophagy
    (3)
  • Adrenergic Receptor
    (2)
  • Cannabinoid Receptor
    (2)
  • Endogenous Metabolite
    (2)
  • Others
    (11)
Filter
Search Result
Results for "

parkinson

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    47
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    1
    TargetMol | Compound_Libraries
  • Natural Products
    6
    TargetMol | Natural_Products
  • Recombinant Protein
    5
    TargetMol | Recombinant_Protein
  • Isotope Products
    3
    TargetMol | Isotope_Products
  • Antibody Products
    9
    TargetMol | Antibody_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
Norharmane
β-Carboline, 2-Azacarbazole, 2,9-Diazafluorene
T4024244-63-3
Norharmane (β-Carboline) is a natural β-carboline first isolated from plants of the Zygophyllaceae family.
  • $30
In Stock
Size
QTY
Vasicinone
TC0039486-64-6
Vasicinone may act as a hepatoprotective agent. (±)-Vasicinone has significant antitussive, expectorant, and bronchodilating activities, which can be used to treat respiratory disease.(S)-Vasicinone exhibits antiproliferative activity against human gastric cancer cells MCG-803.
  • $50
In Stock
Size
QTY
L-DOPA
Levodopa, 3,4-Dihydroxyphenylalanine
T084859-92-7
L-DOPA (Levodopa) is an orally active metabolic precursor of the neurotransmitter dopamine. It can cross the blood-brain barrier and be converted into dopamine in the brain. L-DOPA exhibits anti-hyperalgesic effects and holds potential in Parkinson’s disease research, and it can also be used to induce Parkinson’s disease models.
  • $50
In Stock
Size
QTY
Carbidopa
Lodosyn, (S)-(-)-Carbidopa
T679528860-95-9
Carbidopa (Lodosyn) is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29±2 μM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA.
  • $35
In Stock
Size
QTY
Onjisaponin B
TN114035906-36-6
Onjisaponin B induces autophagy via the AMPK-mTOR signaling pathway, increases the NGF level and accelerates both the removal of mutant huntingtin and A53T α±-synuclein, it may have potential therapeutic effects on Parkinson disease, Alzheimer disease and Huntington disease.
  • $93
In Stock
Size
QTY
Ombuoside
Ombuin-3beta-rutinoside
TN201120188-85-6
Ombuoside (Ombuin-3beta-rutinoside) has antifungal activity. Ombuoside shows significant antioxidant activity in the DPPH, and TEAC, reducing power assays.Ombuoside is a glycoside ombuoside isolated from Gynostemma pentaphyllum.
  • $38
In Stock
Size
QTY
TargetMol | Inhibitor Sale